These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 91570)

  • 1. Purification of the subunit Clq from the first component of equine complement.
    McDonald TL; Burger D
    Immunology; 1979 Jul; 37(3):517-27. PubMed ID: 91570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay.
    Kolb WP; Kolb LM; Podack ER
    J Immunol; 1979 May; 122(5):2103-11. PubMed ID: 109524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of immune complexes by an equine Clq-like factor.
    McDonald TL
    Immunol Commun; 1981; 10(8):741-52. PubMed ID: 6176533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat Clq: isolation and purification from normal serum and development of a sensitive hemolytic assay.
    Leung K; Kerr JS
    Immunol Invest; 1985 Aug; 14(4):283-98. PubMed ID: 3877681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of myeloperoxidase from equine polymorphonuclear leucocytes.
    Mathy-Hartert M; Bourgeois E; Grülke S; Deby-Dupont G; Caudron I; Deby C; Lamy M; Serteyn D
    Can J Vet Res; 1998 Apr; 62(2):127-32. PubMed ID: 9553712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of pig Clq and its structural and functional characterization.
    Simecková J; Dlabac V; Stránský J
    Vet Immunol Immunopathol; 1985 Jun; 9(2):115-30. PubMed ID: 3898551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obtaining of pure transferrins D, M and R from equine serum and determination of transferrin level in relation to phenotype.
    Didkowski S; Kaminski M; Kerjan P; Tomaszewska-Guszkiewicz K; Zurkowski M
    Acta Physiol Pol; 1984; 35(5-6):529-38. PubMed ID: 6545995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.
    Lurhuma AZ; Cambiaso CL; Masson PL; Heremans JF
    Clin Exp Immunol; 1976 Aug; 25(2):212-26. PubMed ID: 954232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of estrogen receptors from MCF-7 human breast cancer cells.
    Chong MT; Lippman M
    Cancer Res; 1980 Sep; 40(9):3172-6. PubMed ID: 7427936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and heterogeneity of human kininogen. Use of DEAE-chromatography, molecular sieving and antibody specific immunosorbents.
    Hamberg U; Elg P; Nissinen E; Stelwagen P
    Int J Pept Protein Res; 1975; 7(3):261-80. PubMed ID: 1158563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and purification of human C1q from plasma.
    Pohl DA; Gibbons JJ; Tsai CC; Roodman ST
    J Immunol Methods; 1980; 36(1):13-27. PubMed ID: 7204993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stepwise dissociation of subcomponents of C1, the first component of human complement, upon activation on an affinity sorbent].
    Kozlov LV; Shoĭbonov BB; Ivanov AE; Zubov VP; Antonov VK
    Biokhimiia; 1989 Oct; 54(10):1745-51. PubMed ID: 2605275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifth component of guinea pig complement: purification and characterization.
    Kinoshita T; Hong K; Kondo K; Inoue K
    J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of the terminal complement complex from target sheep erythrocyte membranes.
    Bhakdi S; Ey P; Bhakdi-Lehnen B
    Biochim Biophys Acta; 1976 Feb; 419(3):445-57. PubMed ID: 1247570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.
    Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
    Gastroenterol Jpn; 1980; 15(1):20-6. PubMed ID: 6153627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat Clq: similarity to human Clq in functional and compositional properties.
    Höffken K; McLaughlin PJ; Price MR; Preston VE; Baldwin RW
    Immunochemistry; 1978 Jun; 15(6):409-12. PubMed ID: 700777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.